Replies to post #186337 on Cytodyn Inc (CYDY)

[StealthGold]

If the EIND and CSP data flopped I would agree with you. Once CYDY management gets involved with trial design then lots of problems. That shows where the problems are.

[misiu143]

No , we know this is not it !!!

Results in CD12 group B showed , that Leronlimab is so ABOVE all SOC drugs that it has no competition …

This study proved leronlimab was the best drug in a world for these covid patients..


All imo